- Home
- RVNC vs ASGI Comparison
RVNC vs ASGI Comparison
Compare RVNC & ASGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- ASGI
- Stock Information
- Founded
- RVNC 1999
- ASGI 2019
- Country
- RVNC United States
- ASGI United States
- Employees
- RVNC N/A
- ASGI N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- ASGI Investment Managers
- Sector
- RVNC Health Care
- ASGI Finance
- Exchange
- RVNC Nasdaq
- ASGI Nasdaq
- Market Cap
- RVNC 599.6M
- ASGI 484.7M
- IPO Year
- RVNC 2014
- ASGI N/A
- Fundamental
- Price
- RVNC $3.84
- ASGI $19.57
- Analyst Decision
- RVNC Buy
- ASGI
- Analyst Count
- RVNC 10
- ASGI 0
- Target Price
- RVNC $10.23
- ASGI N/A
- AVG Volume (30 Days)
- RVNC 2.9M
- ASGI 83.3K
- Earning Date
- RVNC 11-07-2024
- ASGI 01-01-0001
- Dividend Yield
- RVNC N/A
- ASGI 8.76%
- EPS Growth
- RVNC N/A
- ASGI N/A
- EPS
- RVNC N/A
- ASGI N/A
- Revenue
- RVNC $256,945,000.00
- ASGI N/A
- Revenue This Year
- RVNC $20.36
- ASGI N/A
- Revenue Next Year
- RVNC $31.66
- ASGI N/A
- P/E Ratio
- RVNC N/A
- ASGI N/A
- Revenue Growth
- RVNC 25.82
- ASGI N/A
- 52 Week Low
- RVNC $2.30
- ASGI $14.96
- 52 Week High
- RVNC $9.75
- ASGI $18.55
- Technical
- Relative Strength Index (RSI)
- RVNC 34.28
- ASGI 48.96
- Support Level
- RVNC $3.64
- ASGI $19.12
- Resistance Level
- RVNC $4.37
- ASGI $19.80
- Average True Range (ATR)
- RVNC 0.33
- ASGI 0.28
- MACD
- RVNC -0.11
- ASGI 0.04
- Stochastic Oscillator
- RVNC 18.39
- ASGI 56.67
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About ASGI abrdn Global Infrastructure Income Fund of Beneficial Interest
abrdn Global Infrastructure Income Fund is a non-diversified, closed-end management investment company. Its objective is to seek to provide a high level of total return with an emphasis on current income by investing in assets that provide necessary services to society.